← brief for 2026-10-02 · Slowing decline

Imeglimin may improve albuminuria associated with partial suppression of inflammatory and fibrotic markers in diabetic kidney disease

Article No results yet Peer reviewed

Key takeaways

Who did this work

Muta Y (Department of Endocrinology and Diabetes, Fukuoka University School of Medicine , ,) · Yokomizo H (Department of Endocrinology and Diabetes, Fukuoka University School of Medicine , ,) · Kawanami T (Department of Endocrinology and Diabetes, Fukuoka University School of Medicine , ,) · Hamaguchi Y (Department of Regenerative Medicine & Transplantation, Faculty of Medicine, Fukuoka University , ,) · Nagata D (Department of Endocrinology and Diabetes, Fukuoka University School of Medicine , ,) · Yamamoto M (Department of Endocrinology and Diabetes, Fukuoka University School of Medicine , ,) · Senda Y (Department of Endocrinology and Diabetes, Fukuoka University School of Medicine , ,) · Takashi Y (Department of Endocrinology and Diabetes, Fukuoka University School of Medicine , ,) · Kodama S (Department of Regenerative Medicine & Transplantation, Faculty of Medicine, Fukuoka University , ,) · Kawanami D (Department of Endocrinology and Diabetes, Fukuoka University School of Medicine , ,)

Source

Article · Europe PMC, CKD · 2026-09-30
https://europepmc.org/article/PMC/PMC13619504